ARGX vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 01, 2026

ARGX

62.0
AI Score
VS
ARGX Wins

HIVE

52.7
AI Score

Investment Advisor Scores

ARGX

62score
Recommendation
BUY

HIVE

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ARGX HIVE Winner
Forward P/E 34.0136 62.8931 ARGX
PEG Ratio 1.5103 0 Tie
Revenue Growth 62.6% 130.5% HIVE
Earnings Growth 114.0% -99.9% ARGX
Tradestie Score 62.0/100 52.7/100 ARGX
Profit Margin 31.4% -49.9% ARGX
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD ARGX

Frequently Asked Questions

Based on our detailed analysis, ARGX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.